https://www.avient.com/sites/default/files/2021-11/preperm-4-5g-antenna-component-application-snapshot.pdf
L E A D I N G A N T E N N A M A N U FAC T U R E R A N T E N N A C O M P O N E N T S • Extremely tight performance tolerance • Dielectric performance of 3 – 7Dk • Ability to utilize existing injection molding machinery • High mold flow index (MFI) • On demand material delivery • Provided technical support throughout the development of multiple, highly technical materials • Formulated high quality materials that aligned with stringent specification, at a cost effective price • Provided order flexibility, allowing customer to order on demand • Collaborated across the supply chain, enabling customer to take a premium solution to market that can reduce maintenance and construction costs for end users Custom PREPERM™ Low-Loss Dielectric Formulations KEY REQUIREMENTS WHY AVIENT? https://www.preperm.com/ Leading antenna manufacturer
https://www.avient.com/sites/default/files/2024-11/Cesa_ Slip Additives-baby diaper -Case Study Snapshot-CNSHA3OLH90098.pdf
Baby diaper manufactureR B A B Y D I A P E R M A N U FA C T U R E R P P N O N W O V E N M U L T I L A Y E R S • Provide slip additives with high concentrated content • Offer products meeting customer FDA requirements • Shorten supply lead time and reduce cost compared with importing from EU • Offered additives with high concentrated content, which is unachievable for competitors • Provided regulatory support, significant cost and time savings • Compressed the timeline through on-site color visualization, exploration, and formulation of new colors by the expert designer Cesa Slip Additives KEY REQUIREMENTS WHY AVIENT? https://www.avient.com/products/polymer-additives/processing-enhancement-additives/cesa-slip-additives Slide 1: Baby diaper manufactureR
https://www.avient.com/sites/default/files/2024-11/Cesa_ WithStand_ Antimicrobial Additives-Medical Gown-Case study snapshot.pdf
Medical gown manufacturer M E D I C A L G OW N M A N U FAC T U R E R P P N O N W O V E N M U L T I L A Y E R S • Excellent anti-microbial and anti-virus performance • Pass JIS Test • Provide technical support including specific specs, processing and molding recommendations • Customized anti-virus solutions designed to support performance standards for materials used in the surgical environment • Provided technical support for material selection, part & tool design, and process development to accelerate commercialization • Supported customer’s products pass the JIS test Cesa WithStand Antimicrobial Additives KEY REQUIREMENTS WHY AVIENT? https://www.avient.com/products/polymer-additives/repellant-antimicrobial-additives/cesa-withstand-antimicrobial-additives Slide 1: Medical gown manufacturer
https://www.avient.com/sites/default/files/2024-12/Rejoin PCR Colorants - Recycled Printer Cover - case study snapshot.pdf
Home printer OEM HOME PRINTER OEM R E C Y C L E D H I P S I N J E C T I O N C O V E R O F P R I N T E R • Provide PCR-based colorants for a more sustainable solution • Meet both color and mechanical requirements in PCR materials • Offer user-friendly PCR + Colorants solution to address the batch variance problem of PCR in an economical way • Offered revolutionary supply model of PCR + Colorants, ensuring precise quality and color • Helped customers solve the batch variance problem of PCR in a digital way and shortened the color-matching time with PCR Color Prediction Service • Provided on-site technical support to customer Rejoin PCR Colorants KEY REQUIREMENTS WHY AVIENT? https://www.avient.com/products/polymer-colorants/solid-color-masterbatches/rejoin-pcr-colorants Slide 1: Home printer OEM
https://www.avient.com/sites/default/files/2025-01/OnForce LFT-Truck Foot Pedal-Case study Snapshot.pdf
Heavy Truck manufacturer HEAVY TRUCK MANUFACTURER E X T E R I O R S T E P P E D A L • Offer pre-color support to achieve an approved silver color formulation • Provide a metallic look with good weather resistance and wear performance for the exterior part • Shorten development time to gain durability approval • Offered color options that met desired metal color and texture, which was different from an ordinary plastic feel • Achieved excellent wear performance and weather resistance, qualifying it to replace metal • Provided support in achieving durability approval, resulting in significant time and cost savings OnForce Long Glass Fiber Reinforced Polypropylene Composites KEY REQUIREMENTS WHY AVIENT? https://www.avient.com/products/long-fiber-technology/long-fiber-technologies/onforce-long-glass-fiber-reinforced-polypropylene-composites Slide 1: Heavy Truck manufacturer
https://www.avient.com/sites/default/files/2023-07/Avient_CodeConduct_2023_Czech.pdf
Při práci s citlivými dokumenty buďte opatrní. S dodavateli jednáme spravedlivě a profesionálně. http://Avient.com/sustainability 25 Obsah Otázky a odpovědi Otázka: Můj vedoucí mě požádal, abych se řídila novým postupem pro likvidaci odpadu, ale nejsem si jistá, jestli to je bezpečné nebo dokonce legální.
https://www.avient.com/sites/default/files/2020-09/sustainabilityreport2018.pdf
As part of PolyOne’s EHS&S Audit Program, internal experts from corporate EHS&S and the various operations regularly visit sites to validate compliance to internal standards and regulatory requirements. PolyOne’s Global Trade and EHS&S departments share responsibility for supply chain security. PolyOne’s Corporate EHS&S Department is responsible for overseeing environmental protection and resources.
https://www.avient.com/sites/default/files/2024-07/CCG Application Snapshot Evoluscend Mold Release_Final.pdf
PowerPoint Presentation M E D I C A L C O N N E C T O R S • Ongoing production with no change to regular set up • Excellent processing and demolding performance • Color stability during processing • Excellent chemical and impact resistance • Enabled efficient ongoing production rates without changing any processing parameters • Safeguarded color stability and transparency during processing for optimal aesthetics • Ensured regulatory requirements for biocompatible ISO109931 and FDA were met • Provided a solution effective across a range of high-temperature polymers, including PEEK, PPSU, PES, PSU, PEI, LCP, and PPS Colorant Chromatics Evoluscend non- PFAS* high-temperature polymer mold release additive KEY REQUIREMENTS WHY AVIENT AVIENT SOLUTION PRODUCTIVITY + REGULATORY LEARN MORE E L E C T R I C A L C O M P O N E N T O E M (*) A non-PFAS additive manufactured without non-intentionally added (NIA) PFAS or PTFE. (*) manufactured without intentionally added PFAS and without PTFE (1) refers to sulfone products only https://www.avient.com/products/polymer-additives/processing-enhancement-additives/colorant-chromatics-evoluscend-non-pfas-high-temperature-mold-release-additive Slide Number 1
https://www.avient.com/sites/default/files/resources/POL%2520Sidoti%2520IR%2520Presentation%2520w%2520Non%2520GAAP%25203%252018%25202014.pdf
Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation Page 4 • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth • 17 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Steve Newlin Appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2013 2014 and beyond -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $38.38 March 7th, 2014 • 17 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 5 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% United States 66% Europe 14% Canada 7% Asia 6% Latin America 7% PP&S 20% Specialty 53% Distribution 27% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target A dj us te d Ea rn in gs P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 6 PolyOne At A Glance Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2015 % o f O pe ra ti ng In co m e* JV's Performance Products & Solutions Distribution Specialty Specialty OI $5M $46M $87M $195M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 2013 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.2% 12 – 16% Global Specialty Engineered Materials 1.1% 9.3% 12 – 16% Designed Structures & Solutions -- 5.6% 8 – 10% Performance Products & Solutions 5.4% 7.2% 9 – 12% Distribution 2.6% 5.9% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 62% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.1% 15% 4) Adjusted EPS Growth N/A 31% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 Bridge To $2.50 Adjusted EPS By 2015 2015 EPS: $2.50 2013 EPS: $1.31 Mid single digit revenue CAGR Page 9 Mergers & Acquisitions Spartech accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 10 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Healthcare Consumer Packaging and Additive Technology Transportation Page 11 Unique and Innovative Solutions that Help Customers Win https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG Net Debt / EBITDA* = 1.8x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of 2013年12月31日 ($ millions) Page 12 Coupon Rates: 7.500% 7.375% 5.250% Debt Maturities & Pension Funding – 12/31/13 *TTM 12/31/2013 ** includes US-qualified plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2013 Pension Funding** As of 2013年12月31日 Free Cash Flow and Strong Balance Sheet Fund Investment • Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin • Synergy opportunities • Adjacent material solutions • Expanding our sales, marketing, and technical capabilities • Investing in operational and LSS initiatives (including synergy capture) • Manufacturing alignment Organic Growth Share Repurchases Dividends Acquisitions Page 13 $0.16 $0.20 $0.24 $0.32 $0.00 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend • Repurchased ~5 million shares in 2013 • 15 million shares are available for repurchase under the current authorization The New PolyOne: A Specialty Growth Company 2015 Target: $2.50 Adjusted EPS Why Invest In PolyOne? Reconciliation to Condensed Consolidated Balance Sheets 2013 Short-term debt and current portion of long-term debt $ 12.7 Long-term debt 976.2 Less cash and cash equivalents (365.2) Net debt $ 623.7 Adjusted EBITDA 2013 Income before income taxes $ 151.0 Interest expense, net 63.5 Depreciation and amortization 108.8 Special items in EBITDA 31.7 Adjusted EBITDA $ 355.0 2 Platform sales and operating income (OI) 2006Y* 2013Y Global Specialty Engineered Materials sales $ 345.3 $ 615.5 Global Color, Additives and Inks sales 531.8 852.3 Designed Structures and Solutions sales - 597.4 Specialty Platform sales 877.1 2,065.2 Performance Products and Solutions sales 1,166.2 773.2 PolyOne Distribution sales 732.8 1,075.2 Corporate and eliminations (153.7) (142.4) Total sales $ 2,622.4 $ 3,771.2 Global Specialty Engineered Materials OI $ 3.9 $ 57.2 Global Color, Additives and Inks OI 8.9 104.0 Designed Structures & Solutions OI - 33.4 Specialty Platform OI 12.8 194.6 Performance Products and Solutions OI 64.2 56.0 PolyOne Distribution OI 19.2 63.3 Sunbelt Joint Venture OI 102.9 - Corporate and eliminations (4.6) (52.4) Special items in OI 39.1 (30.0) Operating income GAAP 233.6 231.5 Sunbelt equity income (107.0) - Special items in OI (39.1) 30.0 Adjusted operating income $ 87.5 $ 261.5 Global Specialty Engineered Materials - OI % of sales 1.1% 9.3% Global Color, Additives and Inks - OI % of sales 1.7% 12.2% Designed Structures & Solutions - OI % of sales - 5.6% Specialty platform OI - % of sales 1.5% 9.4% PP&S operating OI - % of sales 5.5% 7.2% Distribution OI - % of sales 2.6% 5.9% PolyOne OI adjusted - % of sales 3.3% 6.9% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
https://www.avient.com/sites/default/files/2021-03/avient-antitrust-2021-update-turk-a4.pdf
subject= http:// avient.ethicspoint.com http://www.Avient.com/company/policies-and-governance/ethics-hotline http://www.Avient.com/company/policies-and-governance/ethics-hotline 1. ✓ Před uskutečněním obchodu s konkurentem se poradit s právním oddělením společnosti Avient. × Dohodnout se s kýmkoli na neobchodování s další stranou, nabádat k tomu nebo to nařizovat